Indexing terms

5-fluorouracil, abdominal trachelectomy, abdominal radical trachelectomy, adenocarcinoma, adenoid basal carcinoma, adenoid basal cervical carcinoma, adenoid cystic carcinoma, adenoid cystic cervical carcinoma, adenosarcoma, adenosquamous carcinoma, advanced cervical cancer, advanced cervical carcinoma, advanced cervical disease, advanced disease, advanced stage, atypical carcinoid cervical tumour, atypical carcinoid tumour, basaloid cystic carcinoma, basaloid cystic cervical carcinoma, bevacizumab, biomarker, biopsy, bladder involvement, bleomycin, brachytherapy, brachytherapy boost, cancer antigen 125, cancer antigen 15-3, carboplatin, carcinoembryonic antigen, carcinosarcoma, cemiplimab, cervical adenoid-basal carcinoma, cervical adenoid cystic carcinoma, cervical atypical carcinoid tumour, cervical cancer, cervical carcinosarcoma, cervical carcinoma, cervical clear cell carcinoma, cervical high-grade neuroendocrine carcinoma, cervical low grade neuroendocrine tumour, cervical mixed large cell neuroendocrine carcinoma, cervical mucinous carcinoma, cervical mucinous tumour, cervical pure small cell carcinoma, cervical sarcoma, cervical sarcomatous tumour, cervical small cell neuroendocrine carcinoma, cervical stromal invasion, cervical stromal involvement, cervical typical carcinoid tumour, cervix cancer, cervix uteri, chemotherapy, circulating immune complexes, cisplatin, cis-diamminedichloroplatinum, cis-platinum, clear cell carcinoma, clear cell type, clear margin, clinical staging, clinical trial, clinically occult carcinoma, cold knife conization, colposcopy, combined large cell neuroendocrine carcinoma, combined positive score, combined small cell neuroendocrine carcinoma, complications, computed tomography, cone biopsy, cone resection, cone resection margins, conization, cryopreservation, cystoscopy, cytokeratin fragment 21-1, cytology, definitive treatment, diagnostic work-up, destructive techniques, early cervical cancer, early cervical carcinoma, early cervical disease, early disease, early stage,endovaginal ultrasound, endometrioid adenocarcinoma,excision, excisional techniques, external beam radiation therapy, external beam radiotherapy, extracervical tumour extension, fertility, fertility outcome, fertility preservation, fertility sparing, fertility sparing management, fertility sparing surgery, fertility sparing treatment, FIGO, FIGO staging system, follicular dendritic cell sarcoma, follow-up, follow-up procedures, follow-up protocols, frozen sections, germ cell tumour, gestation, high-grade neuroendocrine carcinoma, high sensitivity C-reactive protein, human papillomavirus-independent adenocarcinoma,human papillomavirus testing, hysterectomy, hysterectomy specimen, image guided adaptive brachytherapy, image guided radiotherapy, imaging, imaging modalities, imaging procedure,imaging test, immunosuppressive acidic protein, intensity modulated radiotherapy, intensive care, intensive care unit, interleukin 6, invasive cervical cancer, invasive cervical carcinoma, invasive cervical disease, invasive disease, invasive stage, isolated tumour cell, laparoscopic staging, laparoscopy, laparotomy, large cell neuroendocrine carcinoma, large loop excision of the transformation zone, laser ablation, laser ablation-destruction, laser conization, laser conization-excision, laser destruction, length of stay, leiomyosarcoma, local clinical diagnostic work-up, local radiological diagnostic work-up, locally advanced cervical cancer, locally advanced cervical carcinoma, locally advanced cervical disease, locally advanced disease, locally advanced stage, long-term survivorship, loop conization, loop electrosurgical excision procedure, low grade neuroendocrine tumour, lymphadenectomy, lymph node, lymph node assessment, lymph node dissection, lymph node staging, lymphovascular space involvement, macrometastatis, magnetic resonance imaging, malignant intestinal obstruction, malignant lymphoma, margin status, mature teratoma,mesonephric type, metastatic cervical cancer, metastatic cervical carcinoma, metastatic cervical disease, metastatic disease, microinvasive cancer, microinvasive cervical cancer, micrometastatis, mixed large cell neuroendocrine carcinoma, mortality rate, mortality analysis, mucinous carcinoma, mucinous tumour, mucoepidermoid carcinoma,multidisciplinary board, multidisciplinary setting, multidisciplinary team, multivariate analysis, myeloid sarcoma, neoadjuvant chemotherapy, neoadjuvant treatment, neonatal intensive care unit admission, nerve-sparing radical surgery, nerve-sparing robotic radical hysterectomy, nodal involvement, non-gestational choriocarcinoma, obstetric outcomes, obstetric risk, occult carcinoma, occult invasive carcinoma, occult invasive cervical cancer, oncologic outcome, oncologic risk, ovarian preservation, ovarian transplantation, ovarian transposition, oxaliplatin, paclitaxel, pain, palliative care, palliative chemotherapy, palliative management, palliative radiotherapy, palliative setting, palliative surgery, palliative systemic treatment, palliative treatment, paraaortic lymphadenectomy, paraaortic lymph node assessement, paraaortice lymph node dissection, parametrial resection, pathological analysis, pathological evaluation, pathological staging, pathology, pathology report, pathology report adequacy, patient-reported outcome, pelvic examination, pelvic lymph node assessement, pelvic lymph node dissection, pelvic lymphadenectomy, perioperative care, physical examination, platinum, platinum-based chemotherapy, positron emission tomography, positron emission tomography/computed tomography, postoperative care, postoperative complications, postoperative recurrence, pregnancy, preterm spontaneous rupture of membranes, preoperative brachytherapy, pregnancy, pregnancy outcome, pregnancy rate, pregnant patient, preoperative care, preoperative work-up, prognosis, prognostic factor, psychosocial suffering, pure small cell carcinoma, quality of health care, quality of life, radiation therapy, radical abdominal trachelectomy, radical surgery, radical trachelectomy, radical vaginal trachelectomy, radiochemotherapy, radiological staging, radiotherapy, rare tumour, rare cervical cancer, rare cervical carcinoma, rectal involvement, rectoscopy, recurrence, recurrent cervical cancer, recurrent cervical carcinoma, recurrent cervical disease, recurrent disease, reoperation, reproduction, reproductive techniques, residual disease, residual tumour, restaging, rhabdomyosarcoma, risk factors, robotic radical hysterectomy, sampling, sarcoma, sarcomatous tumour, sensitivity, sentinel lymph node, sentinel lymph node dissection, sentinel lymph node procedure, sentinel node, serum biomarker, serum marker, simple hysterectomy, simple hysterectomy specimen, specificity, simple trachelectomy, small cell neuroendocrine carcinoma, specialized center,specimen grossing, squamous cell carcinoma antigen, staging, staging procedures,stromal invasion, stromal involvement, supportive care,supportive management, supportive setting, supportive treatment, surgery, surgical lymph node assessment, surgical management, surgical margin, surgical outcome, surgical outcome criteria, surgical procedures, surgical resection, surgical staging, surveillance, survival rate, survival analysis, survivorship, terminal illness, terminally ill patient, tissue polypeptide antigen, TNM, TNM classification, total laparoscopic radical trachelectomy, trachelectomy, transplantation, transposition, transrectal ultrasound, treatment outcome, tumour-associated trypsin inhibitor, tumour necrosis factor alpha, typical carcinoid tumour, undifferentiated carcinoma,ultrastaging, ultrasound, upstaging, uterine cervix cancer, uterine transplantation, vaginal radical trachelectomy, vaginal trachelectomy, vascular space involvement, vascular endothelial growth factor, vincristine, yolk sac tumour.